Company Encyclopedia
View More
name
Cyanotech
CYAN.US
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets.
516.59 B
CYAN.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Personal Care ProductsIndustry
Industry Ranking37/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-20.00%E
    • Profit Margin-7.03%D
    • Gross Margin34.30%C
  • Growth ScoreC
    • Revenue YoY8.47%B
    • Net Profit YoY67.43%A
    • Total Assets YoY0.48%C
    • Net Assets YoY-16.79%E
  • Cash ScoreD
    • Cash Flow Margin-1422.80%E
    • OCF YoY8.47%B
  • Operating ScoreA
    • Turnover1.05A
  • Debt ScoreD
    • Gearing Ratio66.43%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cyanotech Corp Reports Positive Earnings Amid Sales Growth

    Cyanotech Corp (CYAN) reported positive Q2 earnings with a net income of $1,000, a significant turnaround from a $1.15 million loss last year. Sales increased to $6.976 million, driven by demand for its microalgae-based products. Gross profit rose to $2.393 million, while operating expenses decreased. The company reduced short-term bank debt but faces challenges with debt covenant compliance. Management is cautiously optimistic about maintaining financial momentum through cost-saving initiatives and aligning production with market demand, despite potential economic risks.

    Tip Ranks·
    US
    CYAN
    -37.28%
    Tip Ranks·
    US
    CYAN
    -37.28%

    Cyanotech | 10-Q: FY2026 Q2 Revenue: USD 6.976 M

    LB filings·
    US
    CYAN
    -37.28%
    LB filings·
    US
    CYAN
    -37.28%

    Cyanotech Corp (OTCQB: CYAN) reports strong Q2 financial results for fiscal 2026, with CEO noting growth in sales and profitability.

    In Kailua Kona, Hawaii, Cyanotech Corporation (OTCQB: CYAN), a top company in microalgae-based nutrition and health supplements, released its financial report for the quarter ending September 30, 2025. CEO Matthew K. Custer mentioned a positive trend in sales growth and profitability for the second quarter of fiscal year 2026.

    Unusual Whales·
    US
    CYAN
    -37.28%
    Unusual Whales·
    US
    CYAN
    -37.28%

    Cyanotech Corporation reports 19% increase in second quarter sales

    Cyanotech Corporation reported a 19.3% increase in net sales for Q2 fiscal 2026, reaching $7.0 million, up from $5.8 million in Q2 fiscal 2025. Gross profit rose to $2.4 million with a margin of 34.3%, compared to $1.5 million and 25.3% last year. The company reversed an operating loss to report $0.2 million in operating income, and net income improved to $1,000 from a loss of $1.2 million. Growth was attributed to higher bulk sales and strong online performance, alongside increased production and price adjustments for Nutrex products.

    Reuters·
    US
    CYAN
    -37.28%
    Reuters·
    US
    CYAN
    -37.28%

    Cyanotech Corporation Files Initial Statement of Beneficial Ownership for CFO Jennifer A.S. Miyashiro

    Cyanotech Corporation has filed an initial statement of beneficial ownership for CFO Jennifer A.S. Miyashiro, who is identified as the beneficial owner in her roles as CFO, VP Fin & Admin, and Treasurer. The full filing is accessible via the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

    Reuters·
    US
    CYAN
    -37.28%
    Reuters·
    US
    CYAN
    -37.28%
    © 2025 Longbridge｜Disclaimer